Skip to main content

Advertisement

SpringerLink
Log in

An update on idiopathic intracranial hypertension

  • Review Article - Forthcoming Meeting
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Background

Idiopathic intracranial hypertension (IIH) is still a grey area in the knowledge of the aetiology, diagnosis and management of neurosurgical diseases. The definition of IIH has been reviewed over time and many hypotheses have been expressed as cause of the disease. The literature supplies very little evidence-based information to guide our decision-making process when it comes to treat the disease. In this review we sum up the latest information regarding the aetiology and therapy of IIH. Additionally, we make an attempt to unify the diagnostic criteria of Dandy, Friedman and Wall established from 1937 to date.

Method

In this narrative review, we attempt to update the current standpoint to IIH, evaluate the input until now and consider future directions for research. The vast majority of the literature consisted of cohort studies, case control studies, systematic reviews and other narrative reviews.

Results

Pathophysiology: The incidence of IIH is steadily increasing. Several pathophysiological theories have been proposed in the literature based on the flow of cerebrospinal fluid. Diagnosis: We attempt to fuse all the three diagnostic approaches published in the literature that detect IIH, while preserving the individual characteristics of each approach. Treatment: Based on evidence-based trials, the current use of acetazolamide in comparison with placebo or with topiramate has been evaluated. In the interventions’ field, there seems to be a consonance about the alarming symptoms and what the most suitable operation is in each case. There is some disagreement about the indications for venous sinus transversus stenting and its risk/benefit ratio.

Conclusions

Until now there is no class I guideline to which our decision-making can be based on for the management of IIH. A lack of systematic reviews and randomised control trials has been noted. If we focused our research on that, we could develop a standardised treatment protocol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Aboul Enein HA, Abo Khair AF (2008) Idiopathic intracranial hypertension in children: clinical presenations and management. Middle East Afr J Ophthalmol 15(3):113–116

    Article  PubMed  Google Scholar 

  2. Baker RS, Baumann RJ, Buncic JR (1989) Idiopathic intracranial hypertension (pseudomotor cerebri) in pediatric patients. Pediatr Neurol 5(1):5–11

    Article  CAS  PubMed  Google Scholar 

  3. Smith JL (1985) Whence pseudotumour cerebri? J Clin Neuroopthalmol 5(1):55–56

    CAS  Google Scholar 

  4. Baykan B, Ekizoglu E, Altiokka UG (2015) An update on the pathophysiology of idiopathic intracranial hypertension alias pseudomotor cerebri. Agri 27(2):63–72

    PubMed  Google Scholar 

  5. Soler D, Cox T, Bullock P, Calver DM, Robinson RO (1998) Diagnosis and management of benign intracranial hypertension. Arch Dis Child 78:89–94

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Donaldson JO (1981) Pathogenesis of pseudotumour cerebri syndromes. Neurology 31:877–880

    Article  CAS  PubMed  Google Scholar 

  7. Malm J, Kristensen B, Markgren P, Ekstedt J (1992) CSF hydrodynamics in idiopathic intracranial hypertension: a long term study. Neurology 42:851–858

    Article  CAS  PubMed  Google Scholar 

  8. Radhakrishnan K, Thacker AK, Bohlaga NH, Gerryo SE (1993) Epidemiology of Idiopathic intracranial hypertension. A prospective case–control study. J Neurol Sci 116(1):18–28

    Article  CAS  PubMed  Google Scholar 

  9. Raoof N, Sharrack B, Pepper IM, Hickman SJ (2011) The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol 18(10):1266–1268

    Article  CAS  PubMed  Google Scholar 

  10. Bruce BB, Kedar S, Van Stavern GP, Monaghan D, Acierno MD, Braswell RA, Preechawat P, Corbett JJ, Newman NJ, Biousse V (2009) Idiopathic intracranial hypertension in men. Neurology 72(4):304–309

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Kesler A, Gadoth N (2001) Epidemiology of idiopathic intracranial hypertension in Israel. J Neuroophthalmol 21(1):12–14

    Article  CAS  PubMed  Google Scholar 

  12. Biousse V, Bruce BB, Newman NJ (2012) Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 83(5):488–494

    Article  PubMed  PubMed Central  Google Scholar 

  13. Ko MW, Chang SC, Ridha MA, Ney JJ, Ali TF, Friedman DI, Mejico LJ, Volpe NJ, Galetta SL, Balcer LJ, Liu GT (2011) Weight gain and recurrence in idiopathic intracranial hypertension: a case control study. Neurology 76(18):1564–1567

    Article  CAS  PubMed  Google Scholar 

  14. Karaman K, Gverovic-Antunica A, Zuljan I, Vukojevic N, Zoltner B, Erceg I, Ivkosic A (2003) Familial idiopathic intracranial hypertension. Croat Med J 44(4):480–484

    PubMed  Google Scholar 

  15. Kharode C, McAbee G, Sherman J, Kaufman M (1992) Familial intracranial hypertension: report of a case and review of the literature. J Child Neurol 7(2):196–198

    Article  CAS  PubMed  Google Scholar 

  16. Corbett JJ (2008) The first Jacobson Lecture. Familial idiopathic intracranial hypertension. J Neuroophthalmol 28(4):337–347

    Article  PubMed  Google Scholar 

  17. Chebel S, Boughammoura-Bouatay A, Ammar M, Frih-Ayed M (2009) Familial presentation of idiopathic intracranial hypertension. J Neuro-Ophthalmol 33(1–2):65–67

    Article  Google Scholar 

  18. Bidot S, Saindane AM, Pergallo JH, Bruce BB, Newman NJ, Biousse V (2015) Brain imaging in idiopathic intracranial hypertension. J Neuroophthalmol 35(4):400–411

  19. Babikan P, Corbett J, Bell W (1994) Idiopathic intracranial hypertension in children: the Iowa experience. J Child Neurol 9:144–149

    Article  Google Scholar 

  20. Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP, NORDIC Idiopathic Intracranial Hypertension Study Group (2014) The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 71:693–701

    Article  PubMed  PubMed Central  Google Scholar 

  21. Best J, Silvestri G, Burton B, Foot B, Acheson J (2013) The incidence of blindness due to idiopathic intracranial hypertension in the UK. Open Ophthalmol J 7:26–29

    Article  PubMed  PubMed Central  Google Scholar 

  22. Mollan SP, Ali F, Hassan-Smith G, Botfield H, Friedman DI, Sinclair AJ (2016) Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry 87(9):982–992

    Article  PubMed  PubMed Central  Google Scholar 

  23. Wall M, George D (1991) Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 114(Pt 1A):155–180

    PubMed  Google Scholar 

  24. Becker N, Kronenberg G, Harms L, Wiener E, Kreutz K, Eltiri A, Schmidt F, Hoffmann J, Kunte H (2016) Rapid improvement of olfaction after lumbar puncture in a patient with idiopathic intracranial hypertension. Headache. doi:10.1111/head.12802

    Google Scholar 

  25. Bershad EM, Urfy MZ, Calvillo E, Tang R, Cajavilca C, Lee AG, Venkatasubba Rao CP, Suarez JI, Chen D (2014) Marked olfactory impairment in idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 85(9):959–964

    Article  PubMed  Google Scholar 

  26. Liu Z, Dong C, Wang X, Han X, Zhao P, Lv H, Li Q, Wang Z (2015) Association between idiopathic intracranial hypertension and sigmoid sinus dehiscence/diverticulum with pulsatile tinnitus: a retrospective imaging study. Neuroradiology 57(7):747–753

    Article  PubMed  Google Scholar 

  27. Friedman DI (2014) The pseudotumor cerebri syndrome. Neurol Clin 32(2):363–396

    Article  PubMed  Google Scholar 

  28. Kleinschmidt JJ, Digre KB, Hanover R (2000) Idiopathic intracranial hypertension: relationship to depression, anxiety, and quality of life. Neurology 54(2):319–324

    Article  CAS  PubMed  Google Scholar 

  29. Liguori C, Romigi A, Albanese M, Marciani MG, Placidi F, Friedman D, Digre K, Liu G (2014) Revised diagnostic criteria for the pseudomotor cerebri syndrome in adults and children. Neurology 82(19):1752–1753

    Article  PubMed  Google Scholar 

  30. Kahle KT, Kulkarni AV, Limbrick DD, Warf BC (2016) Hydrocephalus in children. Lancet 387(10020):788–799

    Article  PubMed  Google Scholar 

  31. Riggeal BD, Bruce BB, Saindane AM, Ridha MA, Kelly LP, Newman NJ, Biousse V (2013) Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis. Neurology 15;80(3):289–295

    Article  Google Scholar 

  32. Ball AK, Sinclair AJ, Curnow SJ, Tomlinson JW, Burdon MA, Walker EA, Stewart PM, Nightingale PG, Clarke CE, Rauz S (2009) Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance? Clin Endocrinol (Oxf) 70(6):863–869

    Article  CAS  Google Scholar 

  33. Lampl Y, Eshel Y, Kessler A, Fux A, Gilad R, Boaz M, Matas Z, Sadeh M (2002) Serum leptin level in women with idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 72(5):642–643

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Tabassi A, Salmasi AH, Jalali M (2005) Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. Neurology 64(11):1893–1896

    Article  CAS  PubMed  Google Scholar 

  35. Warner JE, Larson AJ, Bhosale P, Digre KB, Henley C, Alder SC, Katz BJ, Bernstein PS (2007) Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J Neuroophthalmol 27(4):258–262

    Article  PubMed  Google Scholar 

  36. Neuro-Ophthalmology Research Disease Investigator (NORDIC) (2016) Available at: www.nordicclinicaltrials.com. Accessed 14 June 2016

  37. Digre KB, Bruce BB, McDermott MP, Galetta KM, Balcer LJ, Wall M (2015) Quality of life in idiopathic intracranial hypertension at diagnosis: IIH Treatment Trial results. Neurology 84(24):2449–2456

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Stiebel-Kalish H, Serov I, Sella R, Chodick G, Snir M (2014) Childhood overweight or obesity increases the risk of IIH recurrence fivefold. Int J Obes (Lond) 38(11):1475–1477

    Article  CAS  Google Scholar 

  39. Jungner M, Siemund R, Venturoli D, Reinstrup P, Schalen W, Bentzer P (2016) Blood–brain barrier permeability following traumatic brain injury. Minerva Anesthesiol 82(5):525–533

    Google Scholar 

  40. O’Brien NF, Maa T, Reuter-Rice K (2015) Noninvasive screening for intracranial hypertension in children with acute, severe traumatic brain injury. J Neurosurg Pediatr 16(4):420–425

    Article  PubMed  Google Scholar 

  41. Bloch O, Auguste KI, Manley GT, Verkman AS (2006) Accelerated progression of kaolin-induced hydrocephalus in aquaporin-4-deficient mice. J Cereb Blood Flow Metab 26(12):1527–1537

    Article  CAS  PubMed  Google Scholar 

  42. Dhungana S, Waters P, Ismail A, Woodroofe N, Vincent A, Sharrack B (2010) Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension. J Neurol 257:1211–1212

    Article  PubMed  Google Scholar 

  43. Kerty E, Heuser K, Indahl UG, Berg PR, Nakken S, Lien S, Omholt SW, Ottersen OP, Nagelhus EA (2013) Is the brain water channel aquaporin-4 a pathogenetic factor in idiopathic intracranial hypertension? Results from a combined clinical and genetic study in a Norwegian cohort. Acta Ophthalmol 91(1):88–91

    Article  CAS  PubMed  Google Scholar 

  44. King LS, Nielsen S, Agre P (1996) Aquaporin-1 water channel protein in lung: ontogeny, steroid-induced expression, and distribution in rat. J Clin Invest 97(10):2183–2191

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Skau M, Goetze JP, Rehfeld JF, Jensen R (2010) Natriuretic pro-peptides in idiopathic intracranial hypertension. Regul Pept 164(2–3):71–77

    Article  CAS  PubMed  Google Scholar 

  46. Bateman GA, Stevens SA, Stimpson J (2009) A mathematical model of idiopathic intracranial hypertension incorporating increased arterial inflow and variable venous outflow collapsibility. J Neurosurg 110:446–456

    Article  PubMed  Google Scholar 

  47. Mukherjee N, Bhatti MT (2014) Update on the surgical management of idiopathic intracranial hypertension. Curr Neurol Neurosci Rep 14(3):438

    Article  PubMed  Google Scholar 

  48. Wong R, Madill SA, Pandey P, Riordan-Eva P (2007) Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatment. BMC Ophthalmol 7:15

    Article  PubMed  PubMed Central  Google Scholar 

  49. Johnston LN, Krohel GB, Madsen RW, March GA (1998) The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudomotor cerebri). Ophthalmology 105(12):2313–2317

    Article  Google Scholar 

  50. Fridley J, Foroozan R, Sherman V, Brandt ML, Yoshor D (2011) Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg 114(1):34–39

    Article  PubMed  Google Scholar 

  51. Millichap JG, Millichap JJ (2015) Mechanism of action of acetazolamide and idiopathic intracranial hypertension. Front Neurol 6:13

    Article  PubMed  PubMed Central  Google Scholar 

  52. The NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee (2014) Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss. The Idiopathic Intracranial Hypertension Treatment Trial. JAMA 311(16):1641–1651

    Article  PubMed Central  Google Scholar 

  53. Piper RJ, Kalyvas AV, Young AMH, Hughes MA, Jamjoom AAB, Fouyas IP (2015) Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev (8):CD003434

  54. Horton JC (2014) Acetazolamide for pseudotumor cerebri: evidence from the NORDIC trial. JAMA 311(16):1618–1619

    Article  PubMed  Google Scholar 

  55. Ball AK, Howman A, Wheatley K, Burdon MA, Matthews T, Jacks AS, Lawden M, Sivaguru A, Furmston A, Howell S, Sharrack B, Davies MB, Sinclair AJ, Clarke CE (2011) A randomised controlled trial of treatment for idiopathic intracranial hypertension. J Neurol 258(5):874–881

    Article  CAS  PubMed  Google Scholar 

  56. Supuran CT (2015) Acetazolamide for the treatment of idiopathic intracranial hypertension. Expert Rev Neurother 15(8):851–856

    Article  CAS  PubMed  Google Scholar 

  57. Celebisoy N, Gokcay F, Sirin H, Akyurekli O (2007) Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 116(5):322–327

    Article  CAS  PubMed  Google Scholar 

  58. Thambisetty M, Lavin PJ, Newman NJ, Biousse V (2007) Fulminant idiopathic intracranial hypertension. Neurology 68(3):229–232

    Article  PubMed  Google Scholar 

  59. Feldon SE (2007) Visual outcomes comparing surgical techniques for management of severe idiopathic intracranial hypertension. Neurosurg Focus 23(5), E6

    Article  PubMed  Google Scholar 

  60. Moreau A, Lao KC, Farris BK (2014) Optic nerve sheath decompression: a surgical technique with minimal operative complications. J Neuroophthalmol 34(1):34–38

    Article  PubMed  Google Scholar 

  61. Corbett JJ, Nerad JA, Tse DT, Anderson RL (1988) Results of optic nerve sheath fenestration for pseudotumor cerebri: the lateral orbitotomy approach. Arch Ophthalmol 106(10):1391–1397

    Article  CAS  PubMed  Google Scholar 

  62. Sergott RC, Savino PJ, Bosley TM (1988) Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch Ophthalmol 106(10):1384–1390

  63. Banta JT, Farris BK (2000) Pseudomotor cerebri and optic nerve sheath decompression. Ophthalmology 107(10):1907–1912

    Article  CAS  PubMed  Google Scholar 

  64. Spitze A, Malik A, Al-Zubidi N, Golnik K, Lee AG (2013) Optic nerve sheath fenestration vs cerebrospinal diversion procedures: what is the preferred surgical procedure for the treatment of idiopathic intracranial hypertension failing maximum medical therapy? J Neuroophthalmol 33(2):183–188

    Article  PubMed  Google Scholar 

  65. Thuente DD, Buckley EG (2005) Pediatric optic nerve sheath decompression. Ophthalmology 112(4):724–727

    Article  PubMed  Google Scholar 

  66. Tarnaris A, Toma AK, Watkins LD, Kitchen ND (2011) Is there a difference in outcomes of patients with idiopathic intracranial hypertension with the choice of cerebrospinal fluid diversion site: a single centre experience. Clin Neurol Neurosurg 113(6):477–479

    Article  PubMed  Google Scholar 

  67. Matloob SA, Toma AK, Thorne L, Watkins LD (2015) Surgically managed idiopathic intracranial hypertension in adults: a single centre experience. Acta Neurochir (Wein) 157(12):2099–2103

    Article  Google Scholar 

  68. Arac A, Lee M, Steinberg GK, Marcellus M, Marks MP (2009) Efficacy of endovascular stenting in dural venous sinus stenosis for the treatment of idiopathic intracranial hypertension. Neurosurg Focus 27(5), E14

    Article  PubMed  Google Scholar 

  69. Radvany MG, Solomon D, Nijjar S, Subramanian PS, Miller NR, Rigamonti D, Blitz A, Gailloud P, Moghekar A (2013) Visual and neurological outcomes following a transverse sinus stenosis. J Neuroophthalmol 33(2):117–122

    Article  PubMed  Google Scholar 

  70. Brazis PW (2008) Clinical review: the surgical treatment of idiopathic pseudomotor cerebri (idiopathic intracranial hypertension). Cephalalgia 28(12):1361–1373

    Article  CAS  PubMed  Google Scholar 

  71. Puffer RC, Mustafa W, Lanzino G (2013) Venous sinus stenting for idiopathic intracranial hypertension: a review of the literature. J Neurointerv Surg 5(5):483–486

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Queen Elizabeth University Hospital, Glasgow, UK

    Mark Portelli

  2. Department of Neurointensive Care Unit, Southampton University Hospital, Tremona Road, SO16 6YD, Southampton, UK

    Panagiotis N. Papageorgiou

Authors
  1. Mark Portelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Panagiotis N. Papageorgiou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Panagiotis N. Papageorgiou.

Ethics declarations

Funding

No funding was received for this research.

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organisation or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

For this type of study formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Portelli, M., Papageorgiou, P.N. An update on idiopathic intracranial hypertension. Acta Neurochir 159, 491–499 (2017). https://doi.org/10.1007/s00701-016-3050-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-016-3050-7

Keywords

Search

Navigation